<DOC>
	<DOCNO>NCT02123134</DOCNO>
	<brief_summary>The objective study explore safety efficacy subcutaneous injection ATX-101 relative placebo , submental area subject 65 75 year old .</brief_summary>
	<brief_title>Safety Study ATX-101 Reduction Localized Subcutaneous Fat Submental Area Subjects 65 75 Years Age</brief_title>
	<detailed_description />
	<mesh_term>Deoxycholic Acid</mesh_term>
	<criteria>Males female , 65 75 year age Stable Body Weight Dissatisfaction submental area express subject Acceptable volume submental fat grade clinician BMI ≤40.0 kg/m2 Signed informed consent ( ICF ) No prior intervention SMF ( eg liposuction , surgery lipolytic agent ) Absence clinically significant health problem History intervention treat SMF ( eg liposuction , surgery , lipolytic agent ) Anatomical feature reduction SMF may result aesthetically unacceptable outcome , judge clinician History trauma associate chin neck area judgment investigator may affect evaluation safety efficacy Body mass index ≤ 40.0 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>